Australia's most trusted
source of pharma news
Tuesday, 28 July 2026
Posted 28 July 2026 AM
Drugs earning hundreds of millions from the PBS are being controlled by a different company after the sponsor was changed this month.
Amgen has expanded a deal with Arrotex, with the generics giant becoming the official 'responsible person' for four brands representing a major market. Arrotex is now the sponsor for Amgen's entire denosumab portfolio, including Xgeva and its generic brand Ganvado, and Prolia along with its generic brand, Corora.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.